Fundies.
English

Segment disclosures

Company overview

Guardian Pharmacy Services, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

2 dimension combinations 20 retained observations 12 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=grdn:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30371070000 USD20261105Open filing evidence
2026-01-01 – 2026-09-301059433000 USD20261105Open filing evidence
2025-07-01 – 2025-09-30377427000 USD20261105Open filing evidence
2025-01-01 – 2025-09-301051069000 USD20261105Open filing evidence

Corporate

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30351768000 USD20260806Open filing evidence
2026-01-01 – 2026-06-30688363000 USD20260806Open filing evidence
2026-01-01 – 2026-03-31336595000 USD20260506Open filing evidence
2025-01-01 – 2025-12-311448685000 USD20260311Open filing evidence
2025-07-01 – 2025-09-30377427000 USD20251110Open filing evidence
2025-01-01 – 2025-09-301051069000 USD20251110Open filing evidence
2025-04-01 – 2025-06-30344334000 USD20260806Open filing evidence
2025-01-01 – 2025-06-30673642000 USD20260806Open filing evidence
2025-01-01 – 2025-03-31329308000 USD20260506Open filing evidence
2024-01-01 – 2024-12-311228409000 USD20260311Open filing evidence
2024-07-01 – 2024-09-30314393000 USD20251110Open filing evidence
2024-01-01 – 2024-09-30889840000 USD20251110Open filing evidence
2024-04-01 – 2024-06-30300037000 USD20250811Open filing evidence
2024-01-01 – 2024-06-30575447000 USD20250811Open filing evidence
2024-01-01 – 2024-03-31275410000 USD20250520Open filing evidence
2023-01-01 – 2023-12-311046193000 USD20250520Open filing evidence